Register
Forgot your password?

Anatomical SYNTAX Score – a tool for coronary arterydisease severity assessment and predicting endovasculartreatment outcomes

Authors: Grigor’ev V.S.1,2, 2, Petrosyan K.V.1, Abrosimov A.V.1, 3

Company: 1Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation;
2 Russian Medical Academy of Continuing Professional Education of Ministry of Health of the Russian Federation, ulitsa Barrikadnaya, 2/1, Moscow, 123995, Russian Federation;
3 Sechenov First Moscow State Medical University of Ministry of Health of the Russian Federation,ulitsa Trubetskaya, 8, stroenie 2, Moscow, 119992, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2019-13-2-159-172

For citation: Grigor’ev V.S., Petrosyan K.V., Abrosimov A.V. Anatomical SYNTAX Score: a tool for coronary artery disease severity assessment and predicting endovascular treatment outcomes. Creative Cardiology. 2019; 13 (2): 159–72 (in Russ.). DOI: 10.24022/1997-3187-2019-13-2-159-172

Received / Accepted:  29.05.2019/07.06.2019

Keywords: SYNTAX Score risk stratification risk score coronary artery disease percutaneous coronary intervention stenting stent thrombosis stent restenosis

Download
Full text:  

 

Abstract

The main options for invasive treatment of coronary artery disease (CAD) are coronary artery bypass grafting and percutaneous coronary interventions. The most severe category are patients with multiple coronary artery lesions. In such cases, a quantitative assessment of CAD severity allows to select comparable groups of patients when choosing a method of myocardial revascularization, to accomplish comparative randomized trials, registries and metaanalyzes. Detailed assessment of the coronary anatomy is a promising model for predicting the results of invasive treatment of CAD contributing to a more balanced decision making. Presently, the most common prognostic model tested in many randomized controlled studies, large registers and meta-analyzes is the SYNTAX Score. The search was performed in the PubMed database and the Scientific Electronic Library with the keyword “SYNTAX Score”. Total of 1,522 matched records were found. Most relevant sources for topic of this paper were selected. Cross-references between databases, reprints, review articles, materials representing comments and discussions of existing publications, studies of similar design and smaller sample size than other published papers, early publications of studies with a shorter observation period were excluded. Priority was given to multicenter randomized controlled trials (RCTs) and meta-analyzes of RCTs. The data of 57 original articles, 3 conference proceedings and 4 guideline documents were summarized. This paper presents main stages of development and characteristics of this risk assessment model, supplemented by a literature review reflecting the prognostic significance and advanced possibilities of the SYNTAX Score in research and clinical practice.

References

  1. Ioseliani D.G., Petrosyan Yu.S. Total valuation of the coronary artery burden in patients with ischemic heart disease. Kardiologiia. 1976; 16 (12): 41–6 (in Russ.).
  2. Friesinger G.C., Page E.E., Ross R.S. Prognostic significance of coronary arteriography. Trans. Assoc. Am. Physicians. 1970; 83: 78–92.
  3. Leaman D.M., Brower R.W., Meester G.T., Serruys P., van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981; 63 (2): 285–99. DOI: 10.1161/01.cir.63.2.285
  4. Sianos G., Morel M.A., Kappetein A.P., Morice M.C., Colombo A., Dawkins K. et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005; 1 (2): 219–27.
  5. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J. et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360 (10): 961–72. DOI: 10.1056/NEJMoa0804626
  6. Head S.J., Kaul S., Mack M.J., Serruys P.W., Taggart D.P., Holmes D.R. et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur. Heart J. 2013; 34 (32): 2510–8. DOI: 10.1093/eurheartj/eht059
  7. Mohr F.W., Morice M.C., Kappetein A.P., Feldman T.E., Ståhle E., Colombo A. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow- up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381 (9867): 629–38. DOI: 10.1016/S0140-6736(13)60141-5
  8. Thuijs D.J., Mohr F.W., Serruys P.W., Mack M.J., Holmes D.R., Morice M.-C. et al. SYNTAXES: Ten-year follow-up from a randomized trial of drug-eluting stents vs bypass surgery in patients with left main and triple vessel disease (preliminary results). Transcatheter Cardiovascular Therapeutics (TCT). Sept. 21–25. USA, San Diego; 2018. Available at: http://www.crtonline.org/presentation- detail/syntaxes-ten-year-follow-up-fromrandomized- trial- (accessed June 21, 2019).
  9. Head S.J., Holmes D.R. Jr., Mack M.J., Serruys P.W., Mohr F.W., Morice M.C. et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc. Interv. 2012; 5 (6): 618–25. DOI: 10.1016/j.jcin.2012.02.013
  10. Capodanno D., Chisari A., Giacoppo D., Bonura S., Lavanco V., Capranzano P. et al. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. Catheter. Cardiovasc. Interv. 2013; 82 (3): 333–40. DOI: 10.1002/ccd.24642
  11. Garg S., Sarno G., Girasis C., Vranckx P., de Vries T., Swart M. et al. A patient-level pooled analysis assessing the impact of the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc. Interv. 2011; 4 (6): 645–53. DOI: 10.1016/j.jcin.2011.02.018
  12. Khan A.R., Golwala H., Tripathi A., Riaz H., Kumar A., Flaherty M.P., Bhatt D.L. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease. Am. J. Cardiol. 2017; 119 (12): 1949–56. DOI: 10.1016/j.amjcard.2017.03.022
  13. Nomura A., Yamaji K., Shirai S., Omata F., Soga Y., Nagashima M. et al. Very long-term outcomes after percutaneous coronary intervention with bare metal stents for unprotected left main coronary artery disease. EuroIntervention. 2012; 8 (8): 962–9. DOI: 10.4244/EIJV8I8A146
  14. Chakravarty T., Buch M.H., Naik H., White A.J., Doctor N., Schapira J. et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am. J. Cardiol. 2011; 107 (3): 360–6. DOI: 10.1016/j.amjcard.2010.09.029
  15. Khairutdinov E.R., Shugushev Z.Kh., Maksim-kin D.A., Arablinsky A.V., Tarichko Yu.V. Peculi-arities of endovascular myocardial revascularization in patients with coronary heart disease and multivascular lesions in the coronary bed. Clinical Medicine. 2012; 90 (7): 20–5 (in Russ.).
  16. Kuznetsov V.A., Bessonov I.S., Pushkarev G.S., Musikhina N.A., Gultyaeva E.P., Zyrianov I.P. et al. Prospective registry of percutaneous coronary interventions: Tyumen Cardiology Center's experience. Patologiya Krovoobrashcheniya i Kardiokhirurgiya (Circulation Pathology and Cardiac Surgery). 2015; 19 (3): 80–6 (in Russ.). DOI: 10.21688/1681-3472-2015-3-80-86
  17. Park S.J., Ahn J.M., Kim Y.H., Park D.W., Yun S.C., Lee J.Y. et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N. Engl. J. Med. 2015; 372 (13): 1204–12. DOI: 10.1056/NEJMoa1415447
  18. Kappetein A.P., Serruys P.W., Sabik J.F., Leon M.B., Taggart D.P., Morice M.C. et al. Design and rationale for a randomised comparison of everolimuseluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial. EuroIntervention. 2016; 12 (7): 861–72. DOI: 10.4244/EIJV12I7A141
  19. Mäkikallio T., Holm N.R., Lindsay M., Spence M.S., Erglis A., Menown I.B. et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016; 388 (10061): 2743–52. DOI: 10.1016/S0140-6736(16)32052-9
  20. Grigoryev V.S., Bockeria L.A., Alekyan B.G., Petrosyan K.V., Karapetyan N.G., Abrosimov A.V. Risk stratification and outcomes of PCI with drug-eluting stents implantation in patients with various comorbidity and complexity of the three-vessel and left main lesion coronary artery disease. Cardio-vascular Diseases. The Bulletin of Bakoulev Center. 2016; 17 (S6): 160 (in Russ.).
  21. Sokolova N.Y., Shumkov K.V., Kuznetsova E.Z., Golukhova E.Z. Results of myocardial revascularization in patients with stable coronary artery disease with high SYNTAX Score. Creative Cardiology. 2017; 11 (2): 109–17 (in Russ.). DOI: 10.24022/1997-3187-2017-11-2-109-117
  22. Franzone A., Taniwaki M., Rigamonti F., Heg D., Piccolo R., Roffi M. et al. Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial. Euro- Intervention. 2016; 12 (5): e595–604. DOI: 10.4244/EIJV12I5A99
  23. Sanchez C.E., Dota A., Badhwar V., Kliner D., Smith A.J., Chu D. et al. Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease. Catheter. Cardiovasc. Interv. 2016; 88 (4): E103–12. DOI: 10.1002/ccd.26276
  24. Kodumuri V., Balasubramanian S., Vij A., Siddamsetti S., Sethi A., Khalafallah R., Khosla S. A meta-analysis comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in unprotected left main disease. Am. J. Cardiol. 2018; 121 (8): 924–33. DOI: 10.1016/j.amjcard.2017.12.039
  25. Kraak R.P., Grundeken M.J., Hassell M.E., Elias J., Koch K.T., Henriques J.P. et al. Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria. EuroIntervention. 2016; 12 (5): e557–65. DOI: 10.4244/EIJV12I5A95
  26. Esper R.B., Farkouh M.E., Ribeiro E.E., Hueb W., Domanski M., Hamza T.H. et al. SYNTAX score in patients with diabetes undergoing coronary revascularization in the FREEDOM trial. J. Am. Coll. Cardiol. 2018; 72 (23 Pt. A): 2826–37. DOI: 10.1016/j.jacc.2018.09.046
  27. Ikeno F., Brooks M.M., Nakagawa K., Kim M.-K., Kaneda H., Mitsutake Y. et al. SYNTAX score and long-term outcomes: the BARI-2D trial. J. Am. Coll. Cardiol. 2017; 69 (4): 395–403. DOI: 10.1016/j.jacc.2016.10.067
  28. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019; 40 (2): 87–165. DOI: 10.1093/eurheartj/ehy394
  29. Nemik D.B., Matyushin G.V., Ustyugov S.A. The prognostic significance of the SYNTAX Score in the risk stratification of patients with STEMI. In: Proceedings of the Actual Issues of the Emergency Cardiology 2017. November 22–24, 2017. Moscow; 2017: 22–3 (in Russ.).
  30. Kul S., Akgul O., Uyarel H., Ergelen M., Kucukdagli O.T., Tasal A. et al. High SYNTAX score predicts worse in-hospital clinical outcomes in patients undergoing primary angioplasty for acute myocardial infarction. Coron. Artery Dis. 2012; 23 (8): 542–8. DOI: 10.1097/MCA. 0b013e3283599486
  31. Choudhary S. Association of syntax score with short-term outcomes among acute ST-elevation myocardial infarction patients undergoing primary PCI. Indian Heart J. 2017; 69 (Suppl. 1): S20–3. DOI: 10.1016/j.ihj.2016.08.002
  32. Urvantseva I.A., Nikolaev K.Yu., Milovanova E.V., Voevoda M.I. Moderate and severe lesion of coronary vessels by SYNTAX score as a predictor for in-hospital complications in myocardial infarction and endovascular treatment. Russian Journal of Cardiology. 2015; 20 (3): 89–92 (in Russ.). DOI: 10.15829/1560-4071-2015-03-89-92
  33. Palmerini T., Genereux P., Caixeta A., Cristea E., Lansky A., Mehran R. et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J. Am. Coll. Cardiol. 2011; 57 (24): 2389–97. DOI: 10.1016/j.jacc.2011.02.032
  34. Zhao C., Wang X., Wu X., Cui L. Early and longterm outcomes after percutaneous coronary intervention of unprotected left main coronary disease with drug-eluting stents in patients with non-STelevation acute coronary syndrome. Can. J. Cardiol. 2011; 27 (6): 743–8. DOI: 10.1016/j.cjca.2011.05.010
  35. Akgun T., Oduncu V., Bitigen A., Karabay C.Y., Erkol A., Kocabay G. et al. Baseline SYNTAX score and long-term outcome in patients with STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin. Appl. Thromb. Hemost. 2015; 21 (8): 712–9. DOI: 10.1177/1076029614521281
  36. Tarasov R.S., Ganukov V.I. Factors of mortality in STelevation myocardial infarction patients with multivessel coronary disease after endovascular revascularization. Complex Issues of Cardiovascular Diseases. 2015; 1: 32–8 (in Russ.). DOI: 10.17802/2306-1278-2015-1-32-38
  37. Brown A.J., McCormick L.M., Gajendragadkar P.R., Hoole S.P., West N.E. Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention. Angiology. 2014; 65 (5): 408–12. DOI: 10.1177/0003319713483542
  38. Yadav M., Généreux P., Palmerini T., Caixeta A., Madhavan M. V., Xu K. et al. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheter. Cardiovasc. Interv. 2015; 85 (1): 1–10. DOI: 10.1002/ccd.25396
  39. DOI: 10.1177/0003319712463816
  40. Oduncu V., Erkol A., Karabay C.Y., 5Sengül C., Tanalp A.C., Fotbolcu H. et al. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention. Int. J. Cardiol. 2013; 168 (4): 3480–5. DOI: 10.1016/j.ijcard.2013.04.166
  41. Madhavan M.V., Généreux P., Rubin J., Palmerini T., Caixeta A., Xu K. et al. Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am. J. Cardiol. 2014; 113 (8): 1331–7. DOI: 10.1016/j.amjcard.2013.12.041
  42. Song P.S., Song Y.B., Lee J.M., Hahn J.Y., Choi S.H., Choi J.H. et al. Major predictors of long-term clinical outcomes after percutaneous coronary intervention for coronary bifurcation lesions with 2-stent strategy: patient-level analysis of the Korean bifurcation pooled cohorts. JACC Cardiovasc. Interv. 2016; 9 (18): 1879–86. DOI: 10.1016/j.jcin.2016.06.049
  43. Luz A., Rodrigues P., Sousa M.J., Silveira I., Anjo D., Brochado B. et al. Thrombus aspiration for reperfusion in myocardial infarction: Predictors and clinical impact of ineffectiveness. Rev. Port. Cardiol. 2014; 33 (12): 753–60 (in Portuguese). DOI: 10.1016/j.repc.2014.05.002
  44. Ayça B., Akin F., Celik O., Cetin S., Sahin I., Gül5sen K. et al. Does SYNTAX score predict inhospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention? Kardiol. Pol. 2014; 72 (9): 806–13. DOI: 10.5603/KP.a2014.0064
  45. Sahin D.Y., Gür M., Elbasan Z., Kuloˇglu O., 5 Seker T., Kivrak A. et al. SYNTAX score is a predictor of angiographic no-reflow in patients with STelevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron. Artery Dis. 2013; 24 (2): 148–53. DOI: 10.1097/MCA.0b013e32835c4719
  46. Wang J.L., Qin Z., Wang Z.J., Shi D.M., Liu Y.Y., Zhao Y.X. et al. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drugeluting stent. J. Geriatr. Cardiol. 2018; 15 (2): 137–45. DOI: 10.11909/j.issn.1671-5411.2018.02.011
  47. Vroegindewey M.M., Schuurman A.S., Kardys I., Anroedh S.S., Oemrawsingh R.M., Ligthart J. et al. SYNTAX score in relation to intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with coronary artery disease. EuroIntervention. 2019; 14 (13): 1408–15. DOI: 10.4244/EIJ-D-17-00827
  48. Wang L., Zhou Y., Peng P., Xu X., Yang S., Liu W. et al. Percutaneous coronary intervention rates and associated independent predictors for progression of nontarget lesions in patients with diabetes mellitus after drug-eluting stent implantation. Angiology. 2016; 67 (1): 12–20. DOI: 10.1177/0003319715578565
  49. Iijima R., Nagashima Y., Sato K., Tokue M., Araki T., Yamazaki K. et al. SYNTAX score predicts major bleeding following drug-eluting stent implantation in an all-comers population. Rev. Esp. Cardiol. (Engl. Ed). 2015; 68 (1): 54–62. DOI: 10.1016/j.rec.2014.02.028
  50. Madhavan M.V., Généreux P., Palmerini T., Caixeta A., Xu K., McAndrew T.C. et al. The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial. J. Invasive Cardiol. 2015; 27 (4): 203–11.
  51. Alekyan B.G., Grigor'yan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment in the Russian Federation (2017). Russian Journal of Endovascular Surgery. 2018; 5 (2): 93–240 (in Russ.). DOI: 10.24183/2409-4080-2018-5-2-93-240
  52. Stefanini G.G., Stortecky S., Cao D., Rat-Wirtzler J., O'Sullivan C.J., Gloekler S. et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur. Heart J. 2014; 35 (37): 2530–40. DOI: 10.1093/eurheartj/ehu074
  53. Witberg G., Regev E., Chen S., Assali A., Barbash I.M., Planer D. et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc. Interv. 2017; 10 (14): 1428–35. DOI: 10.1016/j.jcin.2017.04.035
  54. Shamekhi J., Stundl A., Weber M., Mellert F., Welz A., Grube E. et al. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. Int. J. Cardiol. 2017; 245: 215–21. DOI: 10.1016/j.ijcard.2017.07.082
  55. Windecker S., Kolh P., Alfonso F., Collet J.P., Cremer J., Falk V. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardio-vascular Interventions (EAPCI). Eur. Heart J. 2014; 35 (37): 2541–619. DOI: 10.1093/eurheartj/ ehu278
  56. Roffi M., Patrono C., Collet J.P., Mueller C., Valgimigli M., Andreotti F. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2016; 37 (3): 267–315. DOI: 10.1093/eurheartj/ehv320
  57. Bockeria L.A. (Ed.) Indications for myocardial revascularization (Russian consensus document). Moscow; 2011 (in Russ.).
  58. Capodanno D., Tamburino C. Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time. Int. J. Cardiol. 2012; 159 (3): 165–8. DOI: 10.1016/j.ijcard.2012.01.049
  59. Shiomi H., Tamura T., Niki S., Tada T., Tazaki J., Toma M. et al. Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ. J. 2011; 75 (5): 1130–7. DOI: 10.1253/circj.cj-10-1112
  60. Tanboga I.H., Ekinci M., Isik T., Kurt M., Kaya A., Sevimli S. Reproducibility of syntax score: from core lab to real world. J. Interv. Cardiol. 2011; 24 (4): 302–6. DOI: 10.1111/j.1540-8183.2011.00645.x
  61. Serruys P.W., Onuma Y., Garg S., Sarno G., van den Brand M., Kappetein A.P. et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5 (1): 50–6. DOI: 10.4244/eijv5i1a9
  62. Garg S., Girasis C., Sarno G., Goedhart D., Morel M.A., Garcia-Garcia H.M. et al. The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility. Catheter. Cardiovasc. Interv. 2010; 75 (6): 946–52. DOI: 10.1002/ccd.22372
  63. Généreux P., Palmerini T., Caixeta A., Cristea E., Mehran R., Sanchez R. et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ. Cardiovasc. Interv. 2011; 4 (6): 553–61. DOI: 10.1161/CIRCINTERVENTIONS.111.961862
  64. Cohen D.J., Osnabrugge R.L., Magnuson E.A., Wang K., Li H., Chinnakondepalli K. et al. Costeffectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2014; 130 (14): 1146–57. DOI: 10.1161/CIRCULATIONAHA.114.009985

About Authors

  • Viktor S. Grigor’ev, Endovascular Surgeon, ORCID
  • Karen V. Petrosyan, Cand. Med. Sc., Head of Department, ORCID
  • Andrey V. Abrosimov, Cand. Med. Sc., Endovascular Surgeon,

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by